Metformin Reduces Circulating Factor VII Concentrations in Patients with Type 2 Diabetes mellitus

• References

• 1 Reaven GM. Role of insulin resistance in human disease.. Diabetes 1988; 37: 1595-607.
• 2 Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor-1 levels. A possible link between insulin resistance and atherothrombosis.. Diabetologia 1991; 34: 457-62.
• 3 Heywood D, Mansfield MW, Grant PJ. Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.. Thromb Haemost 1996; 75: 401-7.
• 4 Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen and von Willebrand factor and features of insulin resistance in first degree relatives of patients with NIDDM.. Circulation 1996; 94: 2171-6.
• 5 Grant PJ. The effects of metformin on cardiovascular risk factors.. Diabetes Metab Rev 1995; 11: 543-50.
• 6 Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.. Lancet 1986; 2: 533-7.
• 7 Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo JC. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM Study in healthy men.. Arterioscler Thromb 1994; 14: 54-9.